ESPHIGH SIGNALOPPORTUNITY10-K

ESP delivered exceptional growth with revenue surging 327% to $44M driven by large power supply contracts and significant international expansion.

The company demonstrated remarkable operational leverage with revenue growing 327% while operating income increased only 24%, indicating strong margin expansion and efficient scaling. The substantial increase in cash position to $18.9M and doubled operating cash flow to $21M provides financial flexibility, though the 85% increase in current liabilities warrants monitoring for working capital management.

Comparing 2025-09-16 vs 2024-09-27View on EDGAR →
FINANCIAL ANALYSIS

ESP achieved explosive growth across all key metrics with revenue jumping 327% to $44M, gross profit expanding 330% to $12.7M, and net income soaring 378% to $8.1M, demonstrating exceptional operational leverage. The balance sheet strengthened significantly with cash increasing 333% to $18.9M and operating cash flow nearly doubling to $21M, though current liabilities also rose 85% to $28.3M. Overall, the financial picture signals a company successfully scaling operations and capitalizing on large contract opportunities while maintaining strong cash generation and liquidity.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+377.7%
$1.7M$8.1M

Net income grew 377.7% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
+333.4%
$4.4M$18.9M

Cash position surged 333.4% — strong cash generation or capital raise providing significant financial cushion.

Gross Profit
P&L
+330.2%
$2.9M$12.7M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Revenue
P&L
+326.6%
$10.3M$44.0M

Strong top-line growth of 326.6% — accelerating demand or successful expansion into new markets.

Operating Cash Flow
Cash Flow
+98.1%
$10.6M$21.0M

Operating cash flow surged 98.1% — exceptional cash generation, highest quality earnings signal.

Total Liabilities
Balance Sheet
+85.1%
$15.3M$28.3M

Liabilities grew 85.1% — significant increase in debt or obligations, assess impact on financial flexibility.

Current Liabilities
Balance Sheet
+85.1%
$15.3M$28.3M

Current liabilities surged 85.1% — significant near-term obligations; verify ability to meet short-term debt.

Current Assets
Balance Sheet
+41.2%
$53.2M$75.2M

Current assets grew 41.2% — improving short-term liquidity or inventory/receivables build.

Total Assets
Balance Sheet
+39.9%
$56.5M$79.1M

Asset base grew 39.9% — expansion through organic growth, acquisitions, or capital deployment.

Operating Income
P&L
+24.3%
$6.5M$8.1M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

LANGUAGE CHANGES
NEW — 2025-09-16
PRIOR — 2024-09-27
ADDED
ESP 20250630 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
At September 14, 2025 there were 2,924,418 shares outstanding of the registrant's Common stock, $.33-1/3 par value.
In fiscal years ended June 30, 2025 and 2024, the Company's total sales were $43,950,872 and $38,736,319, respectively.
Sales to six customers accounted for 16%, 13%, 12%, 12%, 11% and 10%, respectively, of total sales in 2025.
Export shipments in fiscal years 2025 and 2024 were $3,124,820 and $2,350,087, respectively.
+7 more — sign up free →
REMOVED
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
At September 24, 2024 there were 2,744,458 shares outstanding of the registrant's Common stock, $.33-1/3 par value.
In fiscal years ended June 30, 2024 and 2023, the Company's total sales were $38,736,319 and $35,592,323, respectively.
Sales to five domestic customers accounted for 23%, 18%, 16%, 13% and 11%, respectively, of total sales in 2023.
Export shipments in fiscal years 2024 and 2023 were $2,350,087 and $549,510, respectively.
+7 more — sign up free →
MORE OPPORTUNITY SIGNALS
IRIXHIGHIRIX demonstrated a dramatic operational turnaround with revenue surging 283% wh...
2026-04-02
CSAIHIGHCSAI underwent a dramatic financial transformation with revenue growing 271% to ...
2026-03-31
PLMKWHIGHPLMKW has entered into a definitive business combination agreement with Controll...
2026-03-31
LXEOHIGHLXEO achieved significant clinical milestones with positive interim data and reg...
2026-03-30
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →